ERIC DOBMEIER Insider Trading $ATRA Atara Biotherapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ERIC DOBMEIER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).

Over the past year ERIC DOBMEIER has been an insider in 2 companies. The total value of shares held by ERIC DOBMEIER in these companies amounts to $240,800.

ERIC DOBMEIER Director
Adaptive Biotechnologies Corp
Director
Aravive, Inc.
Director
Atara Biotherapeutics, Inc.
Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
SEATTLE GENETICS INC /WA
Director
STEMLINE THERAPEUTICS INC
$ 240800 The total value of shares held by ERIC DOBMEIER
Insider Rank

ERIC DOBMEIER ranks 27,846 out of 350,000 insiders. Go to Insider Ranking to see more.

ERIC DOBMEIER in Atara Biotherapeutics, Inc.

Trading Symbol: ATRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Director
Holdings: 16,000 shares
Current Value: $240,800
Latest Transaction: Jul 01 2019
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 17,500
Shares Sold: 0
Share Difference: +17,500
Value Difference: -$80,565

Latest Insider Trading Transactions of ERIC DOBMEIER in Atara Biotherapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000023
Value of Purchases ($)0000039,00039,000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADPT, ARAV, ATRA, SGEN, STML

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 01 2019ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA20.2513,000263,25013,000
Jul 01 2019ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorGrantA0.004,000020,00016 K to 20 K (+25.00 %)
Jul 01 2019ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorBuyP19.502,00039,00016,00014 K to 16 K (+14.29 %)
Jun 18 2018ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA45.655,000228,2505,000
Jun 18 2018ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorGrantA0.001,500014,00012.5 K to 14 K (+12.00 %)
Jun 12 2017ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA13.2021,500283,80021,500
Jun 12 2017ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorGrantA0.005,000012,5007.5 K to 12.5 K (+66.67 %)
Jan 05 2017ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA15.085,50082,9405,500
Jan 05 2017ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorGrantA0.002,00007,5005.5 K to 7.5 K (+36.36 %)
Mar 17 2016ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorBuyP13.863,00041,5655,5002.5 K to 5.5 K (+120.00 %)
Jan 05 2016ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA24.0510,500252,52510,500
Dec 17 2015ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorBuyP22.002,50055,0002,5000 to 2.5 K
Mar 30 2015ATRAAtara Biotherapeut ...DOBMEIER ERICDirectorOption ExerciseA34.9025,000872,50025,000

Page:   1